Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma

NCT00979862 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

47

Enrollment

NIH

Sponsor class

Conditions

Adult Giant Cell Glioblastoma
Adult Glioblastoma
Adult Gliosarcoma
Recurrent Adult Brain Neoplasm

Interventions

DRUG: Cediranib Maleate
DRUG: Cilengitide
OTHER: Laboratory Biomarker Analysis

Sponsor

National Cancer Institute (NCI)